Update On New Therapies For Hematologic Malignancy

Click HERE to access OnDemand Recording 

Click HERE to access CME Evaluation 

Update On New Therapies For Hematologic Malignancy

Presented By:

Huda Salman, MD, PhD, MA

Director of the Brown Center for Immunotherapy, Indiana University School of Medicine

Huda Salman, MD, PhD, is the executive director of the Brown Center for Immunotherapy.
Salman joined IU School of Medicine from Stony Brook University and Stony Brook Cancer Center, where she founded the hematological malignancies section as well as the Cancer Center Adolescence and Young Adult Program.
She completed a fellowship in hematology/oncology at Albert Einstein College of Medicine, residency at Cornell Medical College and medical school at Jordan University. A leukemia survivor herself, Salman’s clinical expertise is focused on hematological malignancies and bone marrow transplantation and cellular therapy, particularly for acute and aggressive lymphomas. Her most recent work on CAR T-cell and immunotherapy is extramurally funded and very well received in the medical community.
At IU School of Medicine, Salman holds the title of Don Brown Chair in Immunotherapy and professor of medicine in the Department of Medicine, Division of Hematology and Oncology.

Accreditation Statement: The Beacon Health System of South Bend is accredited by the Indiana State Medical Association to provide continuing medical education for physicians.

Designation Statement:  Beacon Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure:  The Speaker(s) and all planners associated with this activity do not have any potential conflict of interest.

Disclosure Statement:  As a sponsor accredited by the Indiana State Medical Association, Beacon Health System must ensure balance, independence, objectivity, and scientific rigor in all sponsored educational programs.  All faculty participating in these programs must complete a disclosure statement indicating any real or apparent conflict(s) of interest that may have a direct bearing on the subject matter of the continuing education program.  This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the presentation topic.

Commercial Support:  No commercial support was used in the planning or implementation of this CME activity.

On Demand Details: Recordings are available for credit until 9/7/2023

Questions may be directed to Jenai White at 574.647.7691 or mewhite@beaconhealthsystem.org